Recurrent Platinum-resistant Epithelial Ovarian Cancer
1 clinical trials · Condition
◉ Watch Recurrent Platinum-resistant Epithelial Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors (NCT06724263) | Tasly Biopharmaceuticals Co., Ltd. | 2024-12-01 |
Track Recurrent Platinum-resistant Epithelial Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.